Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weeks-Levy

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Virology|June 1, 1994
Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 virusesN M Mattion, P A Reilly, S J DiMichele, et al.
Developments in Biological Standardization|January 1, 1993
Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccineS J Mento, C Weeks-Levy, J M Tatem, et al.
Virology|December 1, 1991
Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirusC Weeks-Levy, J M Tatem, S J DiMichele, et al.
Virus Research|September 1, 1994
Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptationV B Randolph, M Kandis, P Stemler-Higgins, et al.
Journal of Virology|May 1, 1992
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuatingJ M Tatem, C Weeks-Levy, A Georgiu, et al.
Journal of Biological Standardization|October 1, 1988
Characterization of Vero cellsS K Swanson, S J Mento, C Weeks-Levy, et al.
Journal of Medical Virology|October 1, 1991
Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccineesJ M Tatem, C Weeks-Levy, S J Mento, et al.
Journal of Virology|August 1, 1995
Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein DN M Mattion, P A Reilly, E Camposano, et al.
Microbial Pathogenesis|August 15, 1998
Characterization of mouse lines transgenic with the human poliovirus receptor geneA M Deatly, R E Taffs, J M McAuliffe, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Virology|June 1, 1994
Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 virusesN M Mattion, P A Reilly, S J DiMichele, et al.
Developments in Biological Standardization|January 1, 1993
Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccineS J Mento, C Weeks-Levy, J M Tatem, et al.
Virology|December 1, 1991
Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirusC Weeks-Levy, J M Tatem, S J DiMichele, et al.
Virus Research|September 1, 1994
Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptationV B Randolph, M Kandis, P Stemler-Higgins, et al.
Journal of Virology|May 1, 1992
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuatingJ M Tatem, C Weeks-Levy, A Georgiu, et al.
Journal of Biological Standardization|October 1, 1988
Characterization of Vero cellsS K Swanson, S J Mento, C Weeks-Levy, et al.
Journal of Medical Virology|October 1, 1991
Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccineesJ M Tatem, C Weeks-Levy, S J Mento, et al.
Journal of Virology|August 1, 1995
Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein DN M Mattion, P A Reilly, E Camposano, et al.
Microbial Pathogenesis|August 15, 1998
Characterization of mouse lines transgenic with the human poliovirus receptor geneA M Deatly, R E Taffs, J M McAuliffe, et al.
Pageof 1